Prognostic and Predictive Value of Thyroid Transcription Factor-1, CD56, P40 and Other Clinical Characteristics in Small Cell Lung Cancer Patients
10.3779/j.issn.1009-3419.2017.08.04
- VernacularTitle:TTF-1、CD56、P40免疫组化标志物及其他临床特征与小细胞肺癌预后相关性研究
- Author:
WANG XIN
1
;
ZHANG YI
;
HU MU
;
WANG RUOTIAN
;
LIU LEI
;
QIAN KUN
;
LI YUANBO
;
ZHI XIUYI
Author Information
1. 首都医科大学宣武医院胸外科
- Keywords:
Lung neoplsms;
Prognosis;
Thyroid transcription factor-1
- From:
Chinese Journal of Lung Cancer
2017;20(8):522-527
- CountryChina
- Language:Chinese
-
Abstract:
Background and objective The aim of this study is to explore roles of thyroid transcription factor-1 (TTF-1), CD56, P40 expression and other clinical characteristics predicting response and survival in patients with small cell lung cancer (SCLC).Methods Formalin-fixed, paraffin-embedded biopsy tissues were retrospectively obtained from 198 SCLC patients who were diagnosed first in Xuanwu Hospital. The expressions of TTF-1, CD56 and P40 were detected by im-munohistochemistry. The clinical data including age, gender, cancer stage, Eastern Cooperative Oncology Group (ECOG) score, smoking or not, superior vena cava syndrome (SVCS) due to lung cancer or not were collected.Cox proportional hazard model was used to analyze the relationship between the overall survival (OS) and factors.Results Immunohistochemical staining results showed the positive rate of TTF-1, CD56, P40 were 73.2%, 88.4% and 7.1% respectively. TTF-1 expression (OR=0.665, 95%CI: 0.472-0.937), smoking index ≤400 (OR=1.72, 95%CI: 1.061-2.789) and ECOG=2 (OR=3.551, 95%CI: 2.133-5.914), extensive-stage (OR=2.487, 95%CI: 1.793-3.451) and SVCS due to lung cancer (OR=2.394, 95%CI: 1.49-3.846) were independent prognostic factors for SCLC patients.Conclusion Prognosis of SCLC was related to TTF-1 expression independently after adjusting smoking, ECOG score, stage and SVCS due to lung cancer. Detection of TTF-1, CD56 and P40 expression level might be helpful for predict the prognosis of SCLC.
